SEARCH

Search Details

Taru Hidenori

Faculty of Pharmaceutical Sciences Center for Research and Education on Drug DiscoveryAssociate Professor

Researcher basic information

■ Degree
  • Ph.D., The University of Tokyo
■ URL
researchmap URL■ Various IDs
Researcher number
  • 30533731
ORCID IDJ-Global ID■ Research Keywords and Fields
Research Keyword
  • 老化
  • 神経変性疾患
  • 線虫
  • C. elegans
  • シナプス
  • 神経
Research Field
  • Life Science, Developmental biology
  • Life Science, Cell biology
  • Life Science, Neuroscience-general
  • Life Science, Pharmaceutical hygiene and biochemistry
■ Educational Organization

Career

■ Career
Career
  • Apr. 2015 - Present
    Hokkaido University, Faculty of Pharmaceutical Sciences, Associate Professor
  • Apr. 2013 - Mar. 2015
    Hokkaido University, Faculty of Pharmaceutical Sciences, Lecturer
  • Oct. 2008 - Mar. 2013
    Hokkaido University, Creative Research Institution, Project Assistant Professor
  • Apr. 2008 - Sep. 2008
    University of California, San Diego, Assistant Specialist
  • Jan. 2007 - Mar. 2008
    University of California, San Diego, Postdoctoral Fellow
  • Apr. 2005 - Mar. 2007
    JSPS Overseas Research Fellow
  • Apr. 2004 - Dec. 2006
    University of California, Santa Cruz, Postdoctoral Fellow
  • Apr. 2002 - Mar. 2004
    Hokkaido University, Faculty of Pharmaceutical Sciences, Postdoctoral Fellow
Educational Background
  • Mar. 2002, The University of Tokyo, Graduate School of Pharmaceutical Sciences
  • Mar. 1997, The University of Tokyo, Faculty of Pharmaceutical Sciences, Department of Pharmacy
Committee Memberships
  • Sep. 2013 - Dec. 2023
    American Society for Biochemistry and Molecular Biology, Editorial Board Member for the Journal of Biological Chemistry, Society
  • Jul. 2013 - Feb. 2016
    日本薬学会北海道支部, 幹事, Society

Research activity information

■ Papers
  • Suppression of the amyloidogenic metabolism of APP and the accumulation of Aβ by alcadein α in the brain during aging.
    Keiko Honda; Hiroo Takahashi; Saori Hata; Ruriko Abe; Takashi Saito; Takaomi C Saido; Hidenori Taru; Yuriko Sobu; Kanae Ando; Tohru Yamamoto; Toshiharu Suzuki
    Scientific reports, 14, 1, 18471, 18471, 09 Aug. 2024, [Peer-reviewed], [International Magazine]
    English, Scientific journal, Generation and accumulation of amyloid-β (Aβ) protein in the brain are the primary causes of Alzheimer's disease (AD). Alcadeins (Alcs composed of Alcα, Alcβ and Alcγ family) are a neuronal membrane protein that is subject to proteolytic processing, as is Aβ protein precursor (APP), by APP secretases. Previous observations suggest that Alcs are involved in the pathophysiology of Alzheimer's disease (AD). Here, we generated new mouse AppNL-F (APP-KI) lines with either Alcα- or Alcβ-deficient background and analyzed APP processing and Aβ accumulation through the aging process. The Alcα-deficient APP-KI (APP-KI/Alcα-KO) mice enhanced brain Aβ accumulation along with increased amyloidogenic β-site cleavage of APP through the aging process whereas Alcβ-deficient APP-KI (APP-KI/Alcβ-KO) mice neither affected APP metabolism nor Aβ accumulation at any age. More colocalization of APP and BACE1 was observed in the endolysosomal pathway in neurons of APP-KI/Alcα-KO mice compared to APP-KI and APP-KI/Alcβ-KO mice. These results indicate that Alcα plays an important role in the neuroprotective function by suppressing the amyloidogenic cleavage of APP by BACE1 in the brain, which is distinct from the neuroprotective function of Alcβ, in which p3-Alcβ peptides derived from Alcβ restores the viability in neurons impaired by toxic Aβ.
  • Axonal transport of Frizzled5 by Alcadein α-containing vesicles is associated with kinesin-1.
    Yuzuha Shiraki; Monet Mitsuma; Ritsuko Takada; Saori Hata; Akira Kitamura; Shinji Takada; Masataka Kinjo; Hidenori Taru; Ulrike C Müller; Tohru Yamamoto; Yuriko Sobu; Toshiharu Suzuki
    Molecular biology of the cell, 34, 11, ar110, 01 Oct. 2023, [Peer-reviewed], [International Magazine]
    English, Scientific journal, Alcadein α (Alcα) and amyloid-β protein precursor (APP) are cargo receptors that associate vesicles with kinesin-1. These vesicles, which contain either Alcα or APP, transport various proteins/cargo molecules into axon nerve terminals. Here, we analyzed immune-isolated Alcα- and APP-containing vesicles of adult mouse brains with LC-MS/MS and identified proteins present in vesicles that contained either Alcα or APP. Among these proteins, Frizzled-5 (Fzd5), a Wnt receptor, was detected mainly in Alcα vesicles. Although colocalization ratios of Fzd5 with Alcα are low in the neurites of differentiating neurons by a low expression of Fzd5 in embryonic brains, the suppression of Alcα expression decreased the localization of Fzd5 in neurites of primary cultured neurons. Furthermore, Fzd5-EGFP expressed in primary cultured neurons was preferentially transported in axons with the transport velocities of Alcα vesicles. In synaptosomal fractions of adult-mice brains that express higher levels of Fzd5, the amount of Fzd5 and the phosphorylation level of calcium/calmodulin-dependent protein kinase-II were reduced in the Alcα-deficient mice. These results suggest that reduced transport of Fzd5 by Alcα-containing vesicles associated with kinesin-1 in axon terminals may impair the response to Wnt ligands in the noncanonical Ca2+-dependent signal transduction pathway at nerve terminals of mature neurons.
  • Brain p3-Alcβ peptide restores neuronal viability impaired by Alzheimer's amyloid β-peptide.
    Saori Hata; Haruka Saito; Takeharu Kakiuchi; Dai Fukumoto; Shigeyuki Yamamoto; Kensaku Kasuga; Ayano Kimura; Koichi Moteki; Ruriko Abe; Shungo Adachi; Shoich Kinoshita; Kumiko Yoshizawa-Kumagaye; Hideki Nishio; Takashi Saito; Takaomi C Saido; Tohru Yamamoto; Masaki Nishimura; Hidenori Taru; Yuriko Sobu; Hiroyuki Ohba; Shingo Nishiyama; Norihiro Harada; Takeshi Ikeuchi; Hideo Tsukada; Yasuomi Ouchi; Toshiharu Suzuki
    EMBO molecular medicine, 15, 5, e17052, 30 Mar. 2023, [Peer-reviewed], [International Magazine]
    English, Scientific journal, We propose a new therapeutic strategy for Alzheimer's disease (AD). Brain peptide p3-Alcβ37 is generated from the neuronal protein alcadein β through cleavage of γ-secretase, similar to the generation of amyloid β (Aβ) derived from Aβ-protein precursor/APP. Neurotoxicity by Aβ oligomers (Aβo) is the prime cause prior to the loss of brain function in AD. We found that p3-Alcβ37 and its shorter peptide p3-Alcβ9-19 enhanced the mitochondrial activity of neurons and protected neurons against Aβo-induced toxicity. This is due to the suppression of the Aβo-mediated excessive Ca2+ influx into neurons by p3-Alcβ. Successful transfer of p3-Alcβ9-19 into the brain following peripheral administration improved the mitochondrial viability in the brain of AD mice model, in which the mitochondrial activity is attenuated by increasing the neurotoxic human Aβ42 burden, as revealed through brain PET imaging to monitor mitochondrial function. Because mitochondrial dysfunction is common in the brain of AD patients alongside increased Aβ and reduced p3-Alcβ37 levels, the administration of p3-Alcβ9-19 may be a promising treatment for restoring, protecting, and promoting brain functions in patients with AD.
  • Accumulation of amyloid-β in the brain of mouse models of Alzheimer's disease is modified by altered gene expression in the presence of human apoE isoforms during aging.
    Keiko Honda; Yuhki Saito; Haruka Saito; Megumi Toyoda; Ruriko Abe; Takashi Saito; Takaomi C Saido; Makoto Michikawa; Hidenori Taru; Yuriko Sobu; Saori Hata; Tadashi Nakaya; Toshiharu Suzuki
    Neurobiology of aging, 123, 63, 74, Mar. 2023, [Peer-reviewed], [International Magazine]
    English, Scientific journal, Apolipoprotein E4 (apoE4) is a risk factor for Alzheimer's disease (AD). Here, we investigated brain amyloid-β (Aβ) accumulation throughout the aging process in an amyloid precursor protein (APP) knock-in (KI) mouse model of AD that expresses human APPNL-G-F with or without human apoE4 or apoE3. Brain Aβ42 levels were significantly lower in 9-month-old mice that express human isoforms of apoE than in age-matched APP-KI control mice. Linear accumulation of Aβ42 began in 5-month-old apoE4 mice, and a strong increase in Aβ42 levels was observed in 21-month-old apoE3 mice. Aβ42 levels in cerebroventricular fluid were higher in apoE3 than in apoE4 mice at 6-7 months of age, suggesting that apoE3 is more efficient at clearing Aβ42 than apoE4 at these ages. However, apoE3 protein levels were lower than apoE4 protein levels in the brains of 21-month-old apoE3 and apoE4 mice, respectively, which may explain the rapid increase in brain Aβ42 burden in apoE3 mice. We identified genes that were downregulated in a human apoE-dependent (apoE4 > apoE3) and age-dependent (apoE3 = apoE4) manner, which may regulate brain Aβ burden and/or AD progression. Analysis of gene expression in AD mouse models helps identify molecular mechanisms of pleiotropy by the human APOE gene during aging.
  • Suppression of amyloid-β secretion from neurons by cis-9, trans-11-octadecadienoic acid, an isomer of conjugated linoleic acid.
    Saori Hata; Kuniyuki Kano; Kazunori Kikuchi; Shoichi Kinoshita; Yuriko Sobu; Haruka Saito; Takashi Saito; Takaomi C Saido; Yoshitake Sano; Hidenori Taru; Junken Aoki; Hiroto Komano; Taisuke Tomita; Shunji Natori; Toshiharu Suzuki
    Journal of neurochemistry, 159, 3, 603, 617, Nov. 2021, [Peer-reviewed], [International Magazine]
    English, Scientific journal, Two common conjugated linoleic acids (LAs), cis-9, trans-11 CLA (c9,t11 CLA) and trans-10, cis-12 CLA (t10,c12 CLA), exert various biological activities. However, the effect of CLA on the generation of neurotoxic amyloid-β (Aβ) protein remains unclear. We found that c9,t11 CLA significantly suppressed the generation of Aβ in mouse neurons. CLA treatment did not affect the level of β-site APP-cleaving enzyme 1 (BACE1), a component of active γ-secretase complex presenilin 1 amino-terminal fragment, or Aβ protein precursor (APP) in cultured neurons. BACE1 and γ-secretase activities were not directly affected by c9,t11 CLA. Localization of BACE1 and APP in early endosomes increased in neurons treated with c9,t11 CLA; concomitantly, the localization of both proteins was reduced in late endosomes, the predominant site of APP cleavage by BACE1. The level of CLA-containing phosphatidylcholine (CLA-PC) increased dramatically in neurons incubated with CLA. Incorporation of phospholipids containing c9,t11 CLA, but not t10,c12 CLA, into the membrane may affect the localization of some membrane-associated proteins in intracellular membrane compartments. Thus, in neurons treated with c9,t11 CLA, reduced colocalization of APP with BACE1 in late endosomes may decrease APP cleavage by BACE1 and subsequent Aβ generation. Our findings suggest that the accumulation of c9,t11 CLA-PC/LPC in neuronal membranes suppresses the production of neurotoxic Aβ in neurons.
  • Enhanced amyloid-β generation by γ-secretase complex in DRM microdomains with reduced cholesterol levels.
    Saori Hata; Anqi Hu; Yi Piao; Tadashi Nakaya; Hidenori Taru; Maho Morishima-Kawashima; Shigeo Murayama; Masaki Nishimura; Toshiharu Suzuki
    Human molecular genetics, 29, 3, 382, 393, 01 Feb. 2020, [Peer-reviewed], [International Magazine]
    English, Scientific journal
  • RIMB-1/RIM-Binding Protein and UNC-10/RIM Redundantly Regulate Presynaptic Localization of the Voltage-Gated Calcium Channel inCaenorhabditis elegans
    Yuto Kushibiki; Toshiharu Suzuki; Yishi Jin; Hidenori Taru
    The Journal of Neuroscience, 30 Oct. 2019, [Peer-reviewed], [Corresponding author]
    Scientific journal
  • The cytoplasmic region of the amyloid β-protein precursor (APP) is necessary and sufficient for the enhanced fast velocity of APP transport by kinesin-1.
    Maoko Tsukamoto; Kyoko Chiba; Yuriko Sobu; Yuzuha Shiraki; Yuka Okumura; Saori Hata; Akira Kitamura; Tadashi Nakaya; Seiichi Uchida; Masataka Kinjo; Hidenori Taru; Toshiharu Suzuki
    FEBS letters, 592, 16, 2716, 2724, Aug. 2018, [Peer-reviewed], [International Magazine]
    English, Scientific journal
  • Phosphorylation of KLC1 modifies interaction with JIP1 and abolishes the enhanced fast velocity of APP transport by kinesin-1.
    Kyoko Chiba; Ko-Yi Chien; Yuriko Sobu; Saori Hata; Shun Kato; Tadashi Nakaya; Yasushi Okada; Angus C Nairn; Masataka Kinjo; Hidenori Taru; Rong Wang; Toshiharu Suzuki
    Molecular biology of the cell, 28, 26, 3857, 3869, 15 Dec. 2017, [Peer-reviewed], [Internationally co-authored], [International Magazine]
    English, Scientific journal
  • Effects and mechanisms of prolongevity induced by Lactobacillus gasseri SBT2055 in Caenorhabditis elegans.
    Hisako Nakagawa; Takuya Shiozaki; Eiji Kobatake; Tomohiro Hosoya; Tomohiro Moriya; Fumihiko Sakai; Hidenori Taru; Tadaaki Miyazaki
    Aging cell, 15, 2, 227, 36, Apr. 2016, [Peer-reviewed], [International Magazine]
    English, Scientific journal
  • SYD-1C, UNC-40 (DCC) and SAX-3 (Robo) function interdependently to promote axon guidance by regulating the MIG-2 GTPase.
    Yan Xu; Hidenori Taru; Yishi Jin; Christopher C Quinn
    PLoS genetics, 11, 4, e1005185, Apr. 2015, [Peer-reviewed], [Internationally co-authored], [International Magazine]
    English, Scientific journal
  • Cytoplasmic fragment of Alcadein α generated by regulated intramembrane proteolysis enhances amyloid β-protein precursor (APP) transport into the late secretory pathway and facilitates APP cleavage.
    Norio Takei; Yuriko Sobu; Ayano Kimura; Satomi Urano; Yi Piao; Yoichi Araki; Hidenori Taru; Tohru Yamamoto; Saori Hata; Tadashi Nakaya; Toshiharu Suzuki
    The Journal of biological chemistry, 290, 2, 987, 95, 09 Jan. 2015, [Peer-reviewed], [International Magazine]
    English, Scientific journal
  • Quantitative analysis of APP axonal transport in neurons: role of JIP1 in enhanced APP anterograde transport.
    Kyoko Chiba; Masahiko Araseki; Keisuke Nozawa; Keiko Furukori; Yoichi Araki; Takahide Matsushima; Tadashi Nakaya; Saori Hata; Yuhki Saito; Seiichi Uchida; Yasushi Okada; Angus C Nairn; Roger J Davis; Tohru Yamamoto; Masataka Kinjo; Hidenori Taru; Toshiharu Suzuki
    Molecular biology of the cell, 25, 22, 3569, 80, 05 Nov. 2014, [Peer-reviewed], [Internationally co-authored], [International Magazine]
    English, Scientific journal
  • Increased levels of plasma p3-alcα35, a major fragment of Alcadeinα by γ-secretase cleavage, in Alzheimer's disease.
    Chiori Omori; Madoka Kaneko; Etsuko Nakajima; Hiroyasu Akatsu; Masaaki Waragai; Masahiro Maeda; Maho Morishima-Kawashima; Yuhki Saito; Tadashi Nakaya; Hidenori Taru; Tohru Yamamoto; Takashi Asada; Saori Hata; Toshiharu Suzuki
    Journal of Alzheimer's disease : JAD, 39, 4, 861, 70, 2014, [Peer-reviewed], [International Magazine]
    English, Scientific journal
  • Liprin-α/SYD-2 determines the size of dense projections in presynaptic active zones in C. elegans.
    Maike Kittelmann; Jan Hegermann; Alexandr Goncharov; Hidenori Taru; Mark H Ellisman; Janet E Richmond; Yishi Jin; Stefan Eimer
    The Journal of cell biology, 203, 5, 849, 63, 09 Dec. 2013, [Peer-reviewed], [Internationally co-authored], [International Magazine]
    English, Scientific journal
  • Mechanism of intramembrane cleavage of alcadeins by γ-secretase.
    Yi Piao; Ayano Kimura; Satomi Urano; Yuhki Saito; Hidenori Taru; Tohru Yamamoto; Saori Hata; Toshiharu Suzuki
    PloS one, 8, 4, e62431, Apr. 2013, [Peer-reviewed], [International Magazine]
    English, Scientific journal
  • The Liprin homology domain is essential for the homomeric interaction of SYD-2/Liprin-α protein in presynaptic assembly.
    Hidenori Taru; Yishi Jin
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 31, 45, 16261, 8, 09 Nov. 2011, [Peer-reviewed], [Lead author, Corresponding author], [Internationally co-authored], [International Magazine]
    English, Scientific journal
  • Intracellular trafficking of the amyloid β-protein precursor (APP) regulated by novel function of X11-like.
    Yuhki Saito; Mayu Akiyama; Yoichi Araki; Akio Sumioka; Maki Shiono; Hidenori Taru; Tadashi Nakaya; Tohru Yamamoto; Toshiharu Suzuki
    PloS one, 6, 7, e22108, 2011, [Peer-reviewed], [International Magazine]
    English, Scientific journal
  • Increased amyloidogenic processing of transgenic human APP in X11-like deficient mouse brain.
    Maho Kondo; Maki Shiono; Genzo Itoh; Norio Takei; Takahide Matsushima; Masahiro Maeda; Hidenori Taru; Saori Hata; Tohru Yamamoto; Yuhki Saito; Toshiharu Suzuki
    Molecular neurodegeneration, 5, 1, 35, 35, 15 Sep. 2010, [Peer-reviewed], [International Magazine]
    English, Scientific journal
  • Phosphorylation of the amino-terminal region of X11L regulates its interaction with APP.
    Megumi Sakuma; Emi Tanaka; Hidenori Taru; Susumu Tomita; Sam Gandy; Angus C Nairn; Tadashi Nakaya; Tohru Yamamoto; Toshiharu Suzuki
    Journal of neurochemistry, 109, 2, 465, 75, Apr. 2009, [Peer-reviewed], [Internationally co-authored], [International Magazine]
    English, Scientific journal
  • Regulation of the physiological function and metabolism of AbetaPP by AbetaPP binding proteins.
    Hidenori Taru; Toshiharu Suzuki
    Journal of Alzheimer's disease : JAD, 18, 2, 253, 65, 2009, [Peer-reviewed], [Invited], [Lead author, Corresponding author], [International Magazine]
    English, Scientific journal
  • The novel cargo Alcadein induces vesicle association of kinesin-1 motor components and activates axonal transport.
    Yoichi Araki; Takanori Kawano; Hidenori Taru; Yuhki Saito; Sachiyo Wada; Kanako Miyamoto; Hisako Kobayashi; Hiroyuki O Ishikawa; Yu Ohsugi; Tohru Yamamoto; Kenji Matsuno; Masataka Kinjo; Toshiharu Suzuki
    The EMBO journal, 26, 6, 1475, 86, 21 Mar. 2007, [Peer-reviewed], [International Magazine]
    English, Scientific journal
  • SYD-2 Liprin-alpha organizes presynaptic active zone formation through ELKS.
    Ya Dai; Hidenori Taru; Scott L Deken; Brock Grill; Brian Ackley; Michael L Nonet; Yishi Jin
    Nature neuroscience, 9, 12, 1479, 87, Dec. 2006, [Peer-reviewed], [Internationally co-authored], [International Magazine]
    English, Scientific journal
  • Suppression of the caspase cleavage of beta-amyloid precursor protein by its cytoplasmic phosphorylation.
    Hidenori Taru; Kazuaki Yoshikawa; Toshiharu Suzuki
    FEBS letters, 567, 2-3, 248, 52, 04 Jun. 2004, [Peer-reviewed], [Lead author], [International Magazine]
    English, Scientific journal
  • Facilitation of stress-induced phosphorylation of beta-amyloid precursor protein family members by X11-like/Mint2 protein.
    Hidenori Taru; Toshiharu Suzuki
    The Journal of biological chemistry, 279, 20, 21628, 36, 14 May 2004, [Peer-reviewed], [Lead author], [International Magazine]
    English, Scientific journal
  • Differential roles of JIP scaffold proteins in the modulation of amyloid precursor protein metabolism.
    Hidenori Taru; Yutaka Kirino; Toshiharu Suzuki
    The Journal of biological chemistry, 277, 30, 27567, 74, 26 Jul. 2002, [Peer-reviewed], [Lead author], [International Magazine]
    English, Scientific journal
  • Expression and characterization of the Drosophila X11-like/Mint protein during neural development.
    Momoko Hase; Yoshimasa Yagi; Hidenori Taru; Susumu Tomita; Akio Sumioka; Kazuya Hori; Kanako Miyamoto; Takeshi Sasamura; Makoto Nakamura; Kenji Matsuno; Toshiharu Suzuki
    Journal of neurochemistry, 81, 6, 1223, 32, Jun. 2002, [Peer-reviewed], [Lead author], [International Magazine]
    English, Scientific journal
  • Interaction of Alzheimer's beta -amyloid precursor family proteins with scaffold proteins of the JNK signaling cascade.
    Hidenori Taru; Ko-Ichi Iijima; Momoko Hase; Yutaka Kirino; Yoshimasa Yagi; Toshiharu Suzuki
    The Journal of biological chemistry, 277, 22, 20070, 8, 31 May 2002, [Peer-reviewed], [Lead author], [International Magazine]
    English, Scientific journal
  • Interaction of a neuron-specific protein containing PDZ domains with Alzheimer's amyloid precursor protein
    Susumu Tomita; Toshinori Ozaki; Hidenori Taru; Shinobu Oguchi; Shizu Takeda; Yoshimasa Yagi; Shigeru Sakiyama; Yutaka Kirino; Toshiharu Suzuki
    Journal of Biological Chemistry, 274, 4, 2243, 2254, 22 Jan. 1999, [Peer-reviewed], [International Magazine]
    English, Scientific journal
■ Other Activities and Achievements
■ Books and other publications
  • タンパク質がわかる
    多留偉功; 中矢正; 鈴木利治, タンパク質の構造変化・代謝異常と神経変性疾患
    羊土社, 2003, [Contributor]
■ Syllabus
  • 生命科学研究, 2024年, 修士課程, 生命科学院
  • 生命薬学特論, 2024年, 修士課程, 生命科学院
  • 生命科学実習, 2024年, 修士課程, 生命科学院
  • 先端生物科学実験法Ⅱ, 2024年, 学士課程, 薬学部
  • 生命科学論文講読Ⅰ, 2024年, 修士課程, 生命科学院
  • 生理学, 2024年, 学士課程, 薬学部
  • 生命科学論文講読Ⅱ, 2024年, 修士課程, 生命科学院
  • 細胞生物学Ⅱ, 2024年, 学士課程, 薬学部
  • 基礎実習, 2024年, 学士課程, 薬学部
  • 分析化学実習, 2024年, 学士課程, 薬学部
  • 物理化学実習, 2024年, 学士課程, 薬学部
■ Affiliated academic society
  • THE JAPANESE BIOCHEMICAL SOCIETY
  • THE MOLECULAR BIOLOGY SOCIETY OF JAPAN
  • THE PHARMACEUTICAL SOCIETY OF JAPAN
  • American Society for Biochemistry and Molecular Biology
  • Society for Neuroscience
■ Research Themes
  • Regulatory mechanism of neuronal presynaptic elimination by adaptor molecules and cytoskeletons
    Grants-in-Aid for Scientific Research
    01 Apr. 2023 - 31 Mar. 2026
    多留 偉功
    脳神経系の情報処理機能は、神経細胞間のシナプスと呼ばれる接着構造が適切に形成・維持され、また時に除去されることで実現されている。神経伝達物質の放出を担うプレシナプス(シナプス前部)構造の除去が発生過程あるいは加齢に伴ってどのように制御されているかについては不明な点が多く、その分子機構の理解は神経科学の重要な課題である。代表者らはモデル動物である線虫C. elegansにおいて、微小管の不安定化に起因したプレシナプス異常に関与する二つのアダプター分子を同定した。本研究は神経プレシナプス除去において、これらMAGUKファミリー分子およびLIMドメイン分子がはたす役割とその作用分子機構を明らかにすることを目的とする。さまざまなシナプス異常変異体との遺伝学的相互作用を検討した結果、これらのアダプター分子は微小管不安定化に伴うプレシナプスの除去に対して選択的に関わることが示唆された。アダプター分子の結合分子から予想されるアクチン線維制御との関わりについて遺伝学的に検討し、アダプター分子の作用が当初想定されたアクチン制御とは一部異なる経路による可能性を明らかにした。さらに遺伝子導入による解析から、MAGUKファミリー分子は主に下皮で発現するものの、神経細胞における機能がプレシナプス除去に関わる可能性が示された。シナプス形成・維持・除去の異常は種々の精神疾患・神経疾患に密接に関与しており、本研究はそれらの発症機序を分子レベルで理解する基盤として、治療法開発への貢献が期待される。
    Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (C), Hokkaido University, 23K06128
  • Molecular mechanisms regulating the localization of presynaptic voltage-gated calcium channels
    Grants-in-Aid for Scientific Research
    01 Apr. 2020 - 31 Mar. 2023
    Taru Hidenori
    The nervous system processes information through communication between neurons at synapses. The precise localization of the voltage-gated calcium channel Cav2 as a trigger molecule at presynaptic sites is essential for synaptic transmission. In this study, using the nematode C. elegans as a model organism, we explored molecules involved in the localization of Cav2 through genetic analysis. We newly revealed that the functions of enzymes involved in neuropeptide maturation and glycosylation regulation are important for Cav2 localization at presynaptic sites.
    Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (C), Hokkaido University, 20K07046
  • Regulation of neuronal adaptor molecules by voltage-gated calcium channels at presynaptic structures
    Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C)
    01 Apr. 2016 - 31 Mar. 2020
    Taru Hidenori
    In neuronal presynaptic sites, neurotransmitter release is triggered by voltage-gated calcium channels (VGCC) and supported by unique basal structures with a group of adaptor proteins. In this study, we analyzed the molecular mechanism of protein localization to presynaptic sites focusing on the relationship between VGCC and the adapter molecule RIMB-1/RIM-BP in C. elegans, an invertebrate model animal. We revealed that the localization of VGCC is mainly regulated by the redundant function of two adaptor molecules, RIMB-1 and UNC-10. Moreover, we identified the requirement of VGCC and endocytic proteins for the localization of RIMB-1.
    Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (C), Hokkaido University, 16K08223
  • Molecular mechanisms of presynaptic assembly in serotonergic neurons HSN in C. elegans
    Grants-in-Aid for Scientific Research
    Apr. 2013 - Mar. 2017
    TARU Hidenori
    At presynaptic structures in neurons, Cytomatrix at the Active Zone (CAZ)”, a group of unique adapter proteins, assembles and organizes functional molecules specialized for synaptic transmission. This project addressed the molecular mechanisms of presynaptic assembly mainly in serotonergic neurons HSN in nematode C. elegans: SYD-1, a key regulator of presynaptic assembly, negatively regulates GTPase through the binding of RhoGAP-like domain; RIMB-1, previously uncharacterized CAZ protein, regulates the localization of voltage-gated calcium channels at presynaptic structures.
    Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (C), Hokkaido University, Principal investigator, Competitive research funding, 25460058
  • Roles of SYD-1 and SYD-2 proteins and neuronal trafficking in presynaptic formation
    Grants-in-Aid for Scientific Research
    Apr. 2011 - Mar. 2013
    TARU Hidenori
    Neuronal synapses are cell adhesion structures, which are fundamental units for functions of neuronal system. In nematode C.elegans, SYD (SYnapse Defective) -1 and SYD-2 have been identified as central regulators of presynaptic formation. Based on a large scale modifier screen and genetic analysis, we proposed a possibility that presynaptic components are precisely assembled by SYD-1/SYD-2 pathway under negative regulation involving a cadherin-like cell-adhesion molecule.
    Japan Society for the Promotion of Science, Grant-in-Aid for Young Scientists (B), Hokkaido University, Principal investigator, Competitive research funding, 23790070
  • Regulatory mechanisms of presynaptic assembly by an adaptor protein SYD-2
    Grants-in-Aid for Scientific Research
    Apr. 2009 - Mar. 2011
    TARU Hidenori
    Neuronal synapses are critical cell adhesion structures, which are specialized for intercellular signal transduction between neurons. To understand the molecular mechanisms of synaptic formation is one of the important challenges in neuroscience field and provides better understanding of higher brain function such as learning and memory and neurodegenerative diseases. An adapter protein SYD-2 is a key molecule for presynaptic assembly in nematode C.elegans. In this study, we showed that oligomerization is a critical step for the activation of SYD-2, and identified multiple modifier mutants, which may work together with SYD-2 for presynaptic assembly.
    Japan Society for the Promotion of Science, Grant-in-Aid for Young Scientists (B), Hokkaido University, Principal investigator, Competitive research funding, 21790057
■ Industrial Property Rights
  • βアミロイド生成抑制剤
    Patent right, 鈴木 利治; 多留 偉功; 佐久間 めぐみ; 田中 絵美; 中矢 正, 国立大学法人 北海道大学
    特願2005-139114, 11 May 2005
    特開2006-315982, 24 Nov. 2006
    200903077351557646